Diagnostic value of fusion of metabolic and structural images for stereotactic biopsy of brain tumors without enhancement after contrast medium injection.

CONCLUSION: 18F-FDOPA metabolic imaging is an aid in choosing the target to be biopsied under stereotactic conditions in tumors without MR enhancement. Nevertheless, despite good sensitivity, 18F-FDOPA PET is insufficient for definitive diagnosis of high-grade tumor. PMID: 31560911 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31560911?dopt=Abstract

Source: Neuro-Chirurgie - September 23, 2019 Category: Neurosurgery Authors: Todeschi J, Bund C, Cebula H, Chibbaro S, Lhermitte B, Pin Y, Lefebvre F, Izzie JN, Proust F Tags: Neurochirurgie Source Type: research